ABVC BioPharma, Inc. (ABVC) financial statements and ratios from SEC XBRL: revenue $296000.00 (TTM), net margin -2671.8%, revenue growth -96.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $296000.00 |
| Net Margin | -2671.8% |
| Revenue Growth (YoY) | -96.4% |
| EPS Growth (YoY) | -76.9% |
| Price / Book | 1.91 |
| Price / Sales | 89.14 |
| FCF Yield | -32.7% |
| Altman Z-Score | -4.66 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ABVC overview · ABVC earnings · ABVC KPIs · ABVC investor relations · ABVC ownership · ABVC peers · ABVC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.